Description
Investigation of the concentration of two main breast cancer markers - CA 15-3 and carcinoembryonic antigen (CEA), which is used for prognosis, early detection of tumor recurrence and metastasis, and monitoring of disease treatment.
Period of execution
Within 2 days. The specified time does not include the day of biomaterial collection
Biomaterial type